-
Something wrong with this record ?
Liquid antisolvent crystallization of pharmaceutical compounds: current status and future perspectives
R. Kumar, AK. Thakur, N. Banerjee, A. Kumar, GK. Gaurav, RK. Arya
Language English Country United States
Document type Journal Article, Review
- MeSH
- Technology, Pharmaceutical MeSH
- Crystallization methods MeSH
- Pharmaceutical Preparations MeSH
- Nanoparticles * chemistry MeSH
- Solvents chemistry MeSH
- Solubility MeSH
- Particle Size MeSH
- Water * MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
The present work reviews the liquid antisolvent crystallization (LASC) to prepare the nanoparticle of pharmaceutical compounds to enhance their solubility, dissolution rate, and bioavailability. The application of ultrasound and additives is discussed to prepare the particles with narrow size distribution. The use of ionic liquid as an alternative to conventional organic solvent is presented. Herbal compounds, also known for low aqueous solubility and limited clinical application, have been crystalized by LASC and discussed here. The particle characteristics such as particle size and particle size distribution are interpreted in terms of supersaturation, nucleation, and growth phenomena. To overcome the disadvantage of batch crystallization, the scientific literature on continuous flow reactors is also reviewed. LASC in a microfluidic device is emerging as a promising technique. The different design of the microfluidic device and their application in LASC are discussed. The combination of the LASC technique with traditional techniques such as high-pressure homogenization and spray drying is presented. A comparison of product characteristics prepared by LASC and the supercritical CO2 antisolvent method is discussed to show that LASC is an attractive and inexpensive alternative for nanoparticle preparation. One of the major strengths of this paper is a discussion on less-explored applications of LASC in pharmaceutical research to attract the attention of future researchers.
Department of Chemical Engineering Dr B R Ambedkar National Institute of Technology Jalandhar India
Department of Chemical Engineering Indian Institute of Technology Delhi 110016 New Delhi India
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22031977
- 003
- CZ-PrNML
- 005
- 20230131151815.0
- 007
- ta
- 008
- 230120s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s13346-022-01219-1 $2 doi
- 035 __
- $a (PubMed)35953765
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Kumar, Rahul $u Department of Chemical Engineering, Energy Cluster, University of Petroleum and Energy Studies, Dehradun, 248007, Uttarakhand, India. rahul.iitrahul@gmail.com $1 https://orcid.org/0000000159943749
- 245 10
- $a Liquid antisolvent crystallization of pharmaceutical compounds: current status and future perspectives / $c R. Kumar, AK. Thakur, N. Banerjee, A. Kumar, GK. Gaurav, RK. Arya
- 520 9_
- $a The present work reviews the liquid antisolvent crystallization (LASC) to prepare the nanoparticle of pharmaceutical compounds to enhance their solubility, dissolution rate, and bioavailability. The application of ultrasound and additives is discussed to prepare the particles with narrow size distribution. The use of ionic liquid as an alternative to conventional organic solvent is presented. Herbal compounds, also known for low aqueous solubility and limited clinical application, have been crystalized by LASC and discussed here. The particle characteristics such as particle size and particle size distribution are interpreted in terms of supersaturation, nucleation, and growth phenomena. To overcome the disadvantage of batch crystallization, the scientific literature on continuous flow reactors is also reviewed. LASC in a microfluidic device is emerging as a promising technique. The different design of the microfluidic device and their application in LASC are discussed. The combination of the LASC technique with traditional techniques such as high-pressure homogenization and spray drying is presented. A comparison of product characteristics prepared by LASC and the supercritical CO2 antisolvent method is discussed to show that LASC is an attractive and inexpensive alternative for nanoparticle preparation. One of the major strengths of this paper is a discussion on less-explored applications of LASC in pharmaceutical research to attract the attention of future researchers.
- 650 _2
- $a krystalizace $x metody $7 D003460
- 650 _2
- $a rozpouštědla $x chemie $7 D012997
- 650 12
- $a voda $7 D014867
- 650 12
- $a nanočástice $x chemie $7 D053758
- 650 _2
- $a léčivé přípravky $7 D004364
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a rozpustnost $7 D012995
- 650 _2
- $a farmaceutická technologie $7 D013678
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Thakur, Amit K $u Department of Chemical Engineering, Energy Cluster, University of Petroleum and Energy Studies, Dehradun, 248007, Uttarakhand, India
- 700 1_
- $a Banerjee, Nilanjana $u Department of Chemical Engineering, Energy Cluster, University of Petroleum and Energy Studies, Dehradun, 248007, Uttarakhand, India
- 700 1_
- $a Kumar, Ashutosh $u Department of Chemical Engineering, Indian Institute of Technology Delhi, 110016, New Delhi, India
- 700 1_
- $a Gaurav, Gajendra Kumar $u Sustainable Process Integration Laboratory, SPIL, NETME Centre, Faculty of Mechanical Engineering, Brno University of Technology, VUT Brno, Technická 2896/2, 616 69, Brno, Czech Republic
- 700 1_
- $a Arya, Raj Kumar $u Department of Chemical Engineering, Dr. B.R. Ambedkar National Institute of Technology, Jalandhar, India
- 773 0_
- $w MED00197253 $t Drug delivery and translational research $x 2190-3948 $g Roč. 13, č. 2 (2023), s. 400-418
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35953765 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131151811 $b ABA008
- 999 __
- $a ok $b bmc $g 1891019 $s 1183312
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 13 $c 2 $d 400-418 $e 20220811 $i 2190-3948 $m Drug delivery and translational research $n Drug Deliv Transl Res $x MED00197253
- LZP __
- $a Pubmed-20230120